| Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1 RK Nimmakayala, P Seshacharyulu, I Lakshmanan, S Rachagani, ... Gastroenterology 155 (3), 892-908. e6, 2018 | 85 | 2018 |
| Disruption of C1galt1 gene promotes development and metastasis of pancreatic adenocarcinomas in mice S Chugh, S Barkeer, S Rachagani, RK Nimmakayala, N Perumal, ... Gastroenterology 155 (5), 1608-1624, 2018 | 70 | 2018 |
| Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years BR Hall, A Cannon, P Atri, CS Wichman, LM Smith, AK Ganti, C Are, ... Oncotarget 9 (27), 19396, 2018 | 55 | 2018 |
| Secretory mucin 5AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness K Ganguly, SR Krishn, S Rachagani, R Jahan, A Shah, P Nallasamy, ... Cancer research 81 (1), 91-102, 2021 | 48 | 2021 |
| MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3) RK Kanchan, N Perumal, P Atri, R Chirravuri Venkata, I Thapa, ... Brain Pathology 30 (4), 732-745, 2020 | 42 | 2020 |
| Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker (s) J Carmicheal, A Patel, V Dalal, P Atri, AS Dhaliwal, UA Wittel, MP Malafa, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188318, 2020 | 40 | 2020 |
| Trefoil factor (s) and CA19. 9: a promising panel for early detection of pancreatic cancer R Jahan, K Ganguly, LM Smith, P Atri, J Carmicheal, Y Sheinin, ... EBioMedicine 42, 375-385, 2019 | 36 | 2019 |
| Mucin 5ac serves as the nexus for β-catenin/c-myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance K Ganguly, R Bhatia, S Rauth, A Kisling, P Atri, C Thompson, R Vengoji, ... Gastroenterology 162 (1), 253-268. e13, 2022 | 34 | 2022 |
| Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis S Saxena, Y Hayashi, L Wu, M Awaji, P Atri, ML Varney, A Purohit, ... Oncotarget 9 (5), 5931, 2018 | 26 | 2018 |
| Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring S Chaudhary, R Pothuraju, S Rachagani, JA Siddiqui, P Atri, K Mallya, ... Cancer letters 510, 79-92, 2021 | 20 | 2021 |
| ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation I Lakshmanan, S Chaudhary, R Vengoji, P Seshacharyulu, S Rachagani, ... Molecular Oncology 15 (7), 1866-1881, 2021 | 19 | 2021 |
| CXCR3 and cognate ligands are associated with immune cell alteration and aggressiveness of pancreatic ductal adenocarcinoma A Cannon, CM Thompson, HC Maurer, P Atri, R Bhatia, S West, D Ghersi, ... Clinical Cancer Research 26 (22), 6051-6063, 2020 | 18 | 2020 |
| Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling P Seshacharyulu, S Halder, R Nimmakayala, S Rachagani, S Chaudhary, ... EBioMedicine 75, 2022 | 17 | 2022 |
| Protein phosphatase 2A as a therapeutic target in small cell lung cancer T Mirzapoiazova, G Xiao, B Mambetsariev, MW Nasser, E Miaou, ... Molecular cancer therapeutics 20 (10), 1820-1835, 2021 | 14 | 2021 |
| MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR S Chaudhary, MI Appadurai, SK Maurya, P Nallasamy, S Marimuthu, ... Breast Cancer Research 25 (1), 25, 2023 | 13 | 2023 |
| MUC16 promotes liver metastasis of pancreatic ductal adenocarcinoma by upregulating NRP2-associated cell adhesion S Marimuthu, I Lakshmanan, S Muniyan, SK Gautam, RK Nimmakayala, ... Molecular Cancer Research 20 (8), 1208-1221, 2022 | 12 | 2022 |
| Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer K Ganguly, A Shah, P Atri, S Rauth, MP Ponnusamy, S Kumar, SK Batra Seminars in cancer biology 86, 511-520, 2022 | 11 | 2022 |
| Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma S Saxena, C Molczyk, A Purohit, E Ehrhorn, P Goel, DR Prajapati, P Atri, ... American Journal of Cancer Research 12 (1), 68, 2022 | 11 | 2022 |
| MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB) N Perumal, RK Kanchan, D Doss, N Bastola, P Atri, R Chirravuri-Venkata, ... Acta neuropathologica communications 9, 1-19, 2021 | 11 | 2021 |
| Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma R Vengoji, P Atri, MA Macha, P Seshacharyulu, N Perumal, K Mallya, ... Journal of Experimental & Clinical Cancer Research 40, 1-17, 2021 | 10 | 2021 |
